Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

445 ARTÍCULOS , VIENDO DEL 181 AL 195

A role for sodium glucose cotransporter 2 inhibitors (SGLT2is) in the treatment of Alzheimer's disease?

Esterline R, Oscarsson J, Burns J.

Int Rev Neurobiol. 2020;155:113-140. doi: 10.1016/bs.irn.2020.03.018. Epub 2020 Aug 11.

Harnessing neurogenesis in the adult brain-A role in type 2 diabetes mellitus and Alzheimer's disease

Lazarov O, Minshall RD, Bonini MG.

Int Rev Neurobiol. 2020;155:235-269. doi: 10.1016/bs.irn.2020.03.020.

Therapeutic potentials of neural stem cells in Alzheimer's disease

Wong RSY, Cheong SK.

Malays J Pathol. 2020 Aug;42(2):157-170.

Unwinding Complexities of Diabetic Alzheimer by Potent Novel Molecules

Gupta S, Nair A, Jhawat V, Mustaq N, Sharma A, Dhanawat M, Khan SA.

Am J Alzheimers Dis Other Demen. 2020 Jan-Dec;35:1533317520937542. doi: 10.1177/1533317520937542.

Review of beneficial effects of resveratrol in neurodegenerative diseases such as Alzheimer's disease

Komorowska J, Wątroba M, Szukiewicz D.

Adv Med Sci. 2020 Sep;65(2):415-423. doi: 10.1016/j.advms.2020.08.002. Epub 2020 Aug 29.

ApoE Lipidation as a Therapeutic Target in Alzheimer's Disease

Lanfranco MF, Ng CA, Rebeck GW.

Int J Mol Sci. 2020 Sep 1;21(17):6336. doi: 10.3390/ijms21176336.

Multisite transcranial direct current stimulation in two patients with Alzheimer's disease: A 10-month follow-up study

de Almeida Rodrigues ET, da Silva Machado DG, Leon de Mendonça CTP, da Rocha Souto C, Ries A, Torro N, de Souza IC, Fernández-Calvo B, Andrade SM.

Neurophysiol Clin. 2020 Oct;50(5):393-395. doi: 10.1016/j.neucli.2020.08.001. Epub 2020 Aug 31.

Innovative Therapies and Nanomedicine Applications for the Treatment of Alzheimer's Disease: A State-of-the-Art (2017-2020)

Binda A, Murano C, Rivolta I.

Int J Nanomedicine. 2020 Aug 14;15:6113-6135. doi: 10.2147/IJN.S231480. eCollection 2020.

Memantine Derivatives as Multitarget Agents in Alzheimer's Disease

Marotta G, Basagni F, Rosini M, Minarini A.

Molecules. 2020 Sep 2;25(17):4005. doi: 10.3390/molecules25174005.

Boosting the autophagy-lysosomal pathway by phytochemicals: A potential therapeutic strategy against Alzheimer's disease

Nourbakhsh F, Read MI, Barreto GE, Sahebkar A.

IUBMB Life. 2020 Nov;72(11):2360-2281. doi: 10.1002/iub.2369. Epub 2020 Sep 7.

Adiponectin: The Potential Regulator and Therapeutic Target of Obesity and Alzheimer's Disease

Kim JY, Barua S, Jeong YJ, Lee JE.

Int J Mol Sci. 2020 Sep 3;21(17):6419. doi: 10.3390/ijms21176419.

Memantine, Donepezil, or Combination Therapy-What is the best therapy for Alzheimer's Disease? A Network Meta-Analysis

Guo J, Wang Z, Liu R, Huang Y, Zhang N, Zhang R.

Brain Behav. 2020 Nov;10(11):e01831. doi: 10.1002/brb3.1831. Epub 2020 Sep 10.

Effect of statins on amyloidosis in the rodent models of Alzheimer's disease: Evidence from the preclinical meta-analysis

Rahman SO, Hussain S, Alzahrani A, Akhtar M, Najmi AK.

Brain Res. 2020 Dec 15;1749:147115. doi: 10.1016/j.brainres.2020.147115. Epub 2020 Sep 10.

Editorial: Establishing a Trial Ready Cohort to Accelerate Alzheimer's Clinical Trial Enrollment and Treatments

Meyers EA, Carrillo MC.

J Prev Alzheimers Dis. 2020;7(4):202-203. doi: 10.14283/jpad.2020.42.

Anticoagulants for Treatment of Alzheimer's Disease

Grossmann K.

J Alzheimers Dis. 2020;77(4):1373-1382. doi: 10.3233/JAD-200610.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias